PMV Pharmaceuticals (PMVP)
(Delayed Data from NSDQ)
$1.55 USD
+0.02 (1.31%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 94.12% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.12 |
Next Year | -1.51 |
EPS (TTM) | -0.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.39 | -1.12 | -1.51 |
# of Estimates | 3 | 2 | 5 | 5 |
Most Recent Consensus | -0.35 | -0.36 | -1.03 | -1.57 |
High Estimate | -0.35 | -0.36 | -1.03 | -1.03 |
Low Estimate | -0.39 | -0.41 | -1.38 | -1.92 |
Year ago EPS | -0.34 | -0.31 | -1.44 | -1.12 |
Year over Year Growth Est. | -5.88% | -25.81% | 22.22% | -35.36% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 4 | 1 |
Up Last 60 Days | 1 | 1 | 4 | 1 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 3 |
Down Last 60 Days | 1 | 1 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.39 | -1.12 | -1.51 |
7 Days Ago | -0.36 | -0.38 | -1.17 | -1.49 |
30 Days Ago | -0.35 | -0.37 | -1.36 | -1.48 |
60 Days Ago | -0.35 | -0.37 | -1.36 | -1.48 |
90 Days Ago | -0.35 | -0.37 | -1.36 | -1.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.39 | -1.05 | -1.64 |
Zacks Consensus Estimate | -0.36 | -0.39 | -1.12 | -1.51 |
Earnings ESP | 0.00% | 0.00% | 5.86% | -7.99% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.30 | -0.31 | -0.34 | NA |
Estimate | -0.34 | -0.35 | -0.39 | -0.45 | NA |
Difference | 0.32 | 0.05 | 0.08 | 0.11 | 0.14 |
Surprise | 94.12% | 14.29% | 20.51% | 24.44% | 38.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more